Non-Travel-Associated MERS in Kenya

Researchers report evidence of past Middle East respiratory syndrome coronavirus infection in two people in the country.

Written byMaina Waruru
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, NIAIDScientists studying the zoonotic disease caused by the Middle East respiratory syndrome coronavirus (MERS-CoV) have thus far focused largely on camels, one confirmed animal reservoir of the pathogen. Researchers have also found evidence to suggest the virus may have originated in bats. But a recent finding—MERS antibodies in two people who handle non-camel livestock in northeast Africa—reinforces the idea that camels and bats may not be the only animal reservoirs of MERS-CoV, and suggests that the virus may be endemic to another region, beyond its namesake.

Researchers at the Nairobi, Kenya-based International Livestock Research Institute (ILRI) and at the University of Bonn Medical Center in Germany have found evidence of MERS-CoV antibodies in archived blood samples from two of 1,122 Kenyan livestock handlers, collected between 2013 and 2014. Both people whose blood showed signs of past MERS-CoV infection—a 26-year-old woman and 58-year-old man—were asymptomatic and kept livestock other than camels, the researchers report in the May 2016 issue of Emerging Infectious Diseases. Camels do roam the counties in eastern Kenya where both livestock handlers live, and—as in the Middle East—people in the region consume camel products.

While there have been confirmed cases—even an outbreak—of MERS outside the Middle East, all of these to date have been linked to importations by people ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies